On May 11, 2026, DRCT reported earnings of -6.06 USD per share (EPS) for Q1 26, beating the estimate of -11.79 USD, resulting in a 48.61% surprise. Revenue reached 6.68 million, compared to an expected 6.95 million, with a -3.95% difference. The market reacted with a -7.94% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -17.61 USD, with revenue projected to reach 9.22 million USD, implying an increase of 190.59% EPS, and increase of 37.97% in Revenue from the last quarter.